BFG
GILD icon

Berger Financial Group’s Gilead Sciences GILD Stock Holding History

Berger Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Sell
46,072
-1,074
-2% -$142K 0.3% 72
2026
Q1 		$6.57M Sell
47,146
-14,016
-23% -$1.96M 0.37% 60
2025
Q4 		$7.51M Sell
61,162
-421
-0.7% -$51.2K 0.43% 50
2025
Q3 		$6.84M Sell
61,583
-118
-0.2% -$13.4K 0.41% 55
2025
Q2 		$6.84M Buy
61,701
+415
+0.7% +$44.2K 0.44% 46
2025
Q1 		$6.87M Buy
+61,286
New +$6.32M 0.48% 45
2023
Q2 		– Sell
-2,508
Closed -$208K – 290
2023
Q1 		$208K Sell
2,508
-69,721
-97% -$5.77M 0.03% 259
2022
Q4 		$6.2M Buy
72,229
+853
+1% +$67.5K 0.82% 30
2022
Q3 		$4.4M Buy
71,376
+2,225
+3% +$140K 0.65% 41
2022
Q2 		$4.27M Buy
69,151
+1,511
+2% +$93.6K 0.62% 47
2022
Q1 		$4.02M Buy
+67,640
New +$4.32M 0.51% 60
2021
Q1 		– Sell
-57,942
Closed -$3.38M – 211
2020
Q4 		$3.38M Buy
+57,942
New +$3.5M 0.59% 66

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Berger Financial Group's GILD Position: Q2 2026 in Review

Berger Financial Group reduced its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, selling an estimated $142K and leaving 46,072 shares worth $5.82M. The position accounts for 0.3% of the portfolio, ranked #72.

Berger Financial Group first reported a position in GILD in Q4 2020 and has held it in 12 quarters since. The position peaked at $7.51M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Berger Financial Group held 46,072 shares of Gilead Sciences worth $5.82M as of Q2 2026.
  • Berger Financial Group sold 1,074 Gilead Sciences shares in Q2 2026, an estimated $142K.
  • Gilead Sciences made up 0.3% of Berger Financial Group's portfolio in Q2 2026, its #72 holding.
  • Berger Financial Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 12 quarters since.
  • Berger Financial Group's Gilead Sciences position peaked at $7.51M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Berger Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.